ヒトマイクロバイオーム治療薬の世界市場：2030年までの機会と戦略 - COVID-19の成長と変化

当レポートは、世界のヒトマイクロバイオーム治療薬市場について調査しており、市場規模や予測、動向や戦略、成長および抑制要因、COVID-19の影響、疾患・シーケンシング技術タイプ・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 目次

第3章 図のリスト

第4章 表のリスト

第5章 レポートの構造

第6章 イントロダクション

• 地域セグメンテーション

第7章 ヒトマイクロバイオーム治療薬市場の特徴

• 市場の定義
• 疾患別セグメンテーション
  • 感染症
  • 胃腸障害
  • 代謝障害
  • がん
  • その他
• シーケンシング技術タイプ別セグメンテーション
  • 標的遺伝子
  • RNA
  • 全ゲノムシーケンス（WGS）-ショットガン
  • その他

第8章 市場の動向と戦略

• 戦略的協業と合意
• パイプライン研究と医薬品開発の数の増加
• がんマイクロバイオーム治療薬の開発への投資の増加

第9章 COVID-19の影響

第10章 市場規模と成長

• 市場売上成長予測（2023-2030）
  • 市場成長要因
  • 市場抑制要因

第11章 市場分析：地域別

• 世界市場売上予測：地域別（2023-2030）
• 世界市場売上予測：国別（2023-2030）

第12章 市場セグメンテーション

• 世界市場売上予測：疾患別（2023-2030）
  • 感染症
  • がん
  • 胃腸障害
  • 代謝障害
• 世界市場売上予測：シーケンシング技術タイプ別（2023-2030）
  • 標的遺伝子
  • RNA
  • 全ゲノムショットガン
  • その他のタイプ

第13章 アジア太平洋地域市場

第14章 西欧市場

第15章 東欧市場

第16章 北米市場

第17章 南米市場

第18章 中東市場

第19章 アフリカ市場

第20章 競合情勢

• 企業プロファイル
• Seres Therapeutics
• Assembly Biosciences
• Enterome Bioscience
• Vedanta BioSciences
• Second Genome Inc.

第21章 市場における主要な合併と買収

第22章 市場の機会と戦略

• 2023年の市場：最も新しい機会を提供する国
• 2023年の市場：最も新しい機会を提供するセグメント
• 2023年の市場：成長戦略
  • 市場動向ベースの戦略
  • 競合の戦略

第23章 結論・提言

• 結論
• 提言

第24章 付録

Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global human microbiome therapeutics market.

Reasons to Purchase

• Outperform competitors using accurate up to date demand-side dynamics information.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Identify growth segments for investment.
• Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
• Create regional and country strategies on the basis of local data and analysis.
• Stay abreast of the latest customer and market research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future developments.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Gain a global perspective on the development of the market.

Where is the largest and fastest growing market for the human microbiome therapeutics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global human microbiome therapeutics market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.

The report covers the following chapters

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by disease, and by sequencing technology type.

Market Characteristics - The market characteristics section of the report defines and explains the human microbiome therapeutics market. This chapter also defines and describes products covered in the report.

Trends And Strategies - This chapter describes the major trends shaping the global human microbiome therapeutics market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

COVID Impact Analysis - This section provides an insight on how the pandemic is impacting the human microbiome therapeutics market.

Global Market Size And Growth - This section contains the global forecast (2023-2025), (2025-2030) market values, and drivers and restraints that support and control the growth of the market in the forecast periods.

Regional Analysis - This section contains the forecast (2023-2025), and (2025-2030) market values and growth and market share comparison by region.

Segmentation - This section contains the market values (2023-2030) and analysis for different segments.

Regional Market Size and Growth - This section contains the region's market size forecast (2023-2025), and (2025-2030) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, South America, Middle East and Africa and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global human microbiome therapeutics market, estimated market shares and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for human microbiome therapeutics companies in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: The global human microbiome therapeutics market is segmented into -

By Disease: Infectious Diseases; Gastrointestinal Disorders; Metabolic Disorders; Cancers; Other Diseases

By Sequencing Technology Type: Targeted Gene; RNA; Whole-Genome Shotgun (WGS); Others Types

Companies Mentioned: Seres Therapeutics; Assembly Biosciences; Enterome Bioscience; Vedanta BioSciences; Second Genome Inc.

Countries: China, India, Japan, Australia, Indonesia, South Korea, USA, Brazil, France, Germany, UK, Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Human Microbiome Therapeutics Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

• 6.1. Segmentation By Geography

7. Human Microbiome Therapeutics Market Characteristics

• 7.1. Market Definition
• 7.2. Segmentation By Disease
  • 7.2.1. Infectious Diseases
  • 7.2.2. Gastrointestinal Disorders
  • 7.2.3. Metabolic Disorders
  • 7.2.4. Cancers
  • 7.2.5. Other Diseases
• 7.3. Segmentation By Sequencing Technology Type
  • 7.3.1. Targeted Gene
  • 7.3.2. RNA
  • 7.3.3. Whole-Genome Sequencing (WGS)- Shotgun
  • 7.3.4. Others Types

8. Human Microbiome Therapeutics Market Trends And Strategies

• 8.1. Strategic Collaborations And Agreements
• 8.2. Increasing Number Of Pipeline Studies And Drug Development
• 8.3. Increasing Investments On Development Of Cancer Microbiome Therapeutics

9. COVID Impact Human Microbiome Therapeutics Market

10. Global Human Microbiome Therapeutics Market Size And Growth

• 10.1. Forecast Market Growth, 2023 - 2030, Value ($ Million)
  • 10.1.1. Drivers Of The Market 2023 - 2030
  • 10.1.2. Restraints On The Market 2023 - 2030

11. Human Microbiome Therapeutics Market, Regional Analysis

• 11.1. Global Human Microbiome Therapeutics Market, By Region, Forecast, 2023 - 2030, Value ($ Million)
• 11.2. Global Human Microbiome Therapeutics Market, By Country, Forecast, 2023 - 2030, Value ($ Million)

12. Global Human Microbiome Therapeutics Market Segmentation

• 12.1. Global Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
  • 12.1.1. Infectious Diseases
  • 12.1.2. Cancers
  • 12.1.3. Gastrointestinal Disorders
  • 12.1.4. Metabolic Disorders
• 12.2. Global Human Microbiome Therapeutics Market, Segmentation By Sequencing Technology Type, Forecast, 2023 - 2030, Value ($ Million)
  • 12.2.1. Targeted Gene
  • 12.2.2. RNA
  • 12.2.3. Whole-genome Shotgun
  • 12.2.4. Other Type

13. Asia-Pacific Human Microbiome Therapeutics Market

• 13.1. Asia-Pacific Human Microbiome Therapeutics Market Overview
  • 13.1.1. Region Information
  • 13.1.2. Impact of COVID-19
  • 13.1.3. Market Information
  • 13.1.4. Background Information
  • 13.1.5. Government Initiatives
  • 13.1.6. Regulations
  • 13.1.7. Regulatory Bodies
  • 13.1.8. Major Associations
  • 13.1.9. Taxes Levied
  • 13.1.10. Corporate Tax Structure
  • 13.1.11. Investment
  • 13.1.12. Major Companies
• 13.2. Asia-Pacific Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 13.3. Asia-Pacific Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 13.4. Asia-Pacific Human Microbiome Therapeutics Market: Country Analysis
• 13.5. China Human Microbiome Therapeutics Market
• 13.6. China Human Microbiome Therapeutics Market Overview
  • 13.6.1. Country Information
  • 13.6.2. Impact of COVID-19
  • 13.6.3. Market Information
  • 13.6.4. Background Information
  • 13.6.5. Regulations
  • 13.6.6. Regulatory Bodies
  • 13.6.7. Major Associations
  • 13.6.8. Corporate Tax Structure
  • 13.6.9. Investment
  • 13.6.10. Major Companies
• 13.7. China Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 13.8. China Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 13.9. India Human Microbiome Therapeutics Market
• 13.10. India Human Microbiome Therapeutics Market Overview
  • 13.10.1. Country Information
  • 13.10.2. Impact of COVID-19
  • 13.10.3. Market Information
  • 13.10.4. Background Information
  • 13.10.5. Government Initiatives
  • 13.10.6. Regulations
  • 13.10.7. Regulatory Bodies
  • 13.10.8. Major Associations
  • 13.10.9. Corporate Tax Structure
  • 13.10.10. Major Companies
• 13.11. India Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 13.12. India Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 13.13. Japan Human Microbiome Therapeutics Market
• 13.14. Japan Human Microbiome Therapeutics Market Overview
  • 13.14.1. Country Information
  • 13.14.2. Impact of COVID-19
  • 13.14.3. Market Information
  • 13.14.4. Background Information
  • 13.14.5. Regulations
  • 13.14.6. Regulatory Bodies
  • 13.14.7. Corporate Tax Structure
  • 13.14.8. Investment
  • 13.14.9. Major Companies
• 13.15. Japan Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 13.16. Japan Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 13.17. Australia Human Microbiome Therapeutics Market
• 13.18. Australia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 13.19. Australia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 13.20. Indonesia Human Microbiome Therapeutics Market
• 13.21. Indonesia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 13.22. Indonesia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 13.23. South Korea Human Microbiome Therapeutics Market
• 13.24. South Korea Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 13.25. South Korea Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

14. Western Europe Human Microbiome Therapeutics Market

• 14.1. Western Europe Human Microbiome Therapeutics Market Overview
  • 14.1.1. Region Information
  • 14.1.2. Impact Of COVID-19
  • 14.1.3. Market Information
  • 14.1.4. Background Information
  • 14.1.5. Government initiatives
  • 14.1.6. Regulations
  • 14.1.7. Regulatory Bodies
  • 14.1.8. Major Associations
  • 14.1.9. Taxes Levied
  • 14.1.10. Corporate Tax Structure
  • 14.1.11. Investment
  • 14.1.12. Major Companies
• 14.2. Western Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 14.3. Western Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 14.4. Western Europe Human Microbiome Therapeutics Market: Country Analysis
• 14.5. UK Human Microbiome Therapeutics Market
• 14.6. UK Human Microbiome Therapeutics Market Overview
  • 14.6.1. Country Information
  • 14.6.2. Impact Of COVID-19
  • 14.6.3. Market Information
  • 14.6.4. Background Information
  • 14.6.5. Government Initiatives
  • 14.6.6. Regulations
  • 14.6.7. Regulatory Bodies
  • 14.6.8. Major Associations
  • 14.6.9. Taxes Levied
  • 14.6.10. Corporate Tax Structure
  • 14.6.11. Investment
  • 14.6.12. Major Companies
• 14.7. UK Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 14.8. UK Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 14.9. Germany Human Microbiome Therapeutics Market
• 14.10. Germany Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 14.11. Germany Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 14.12. France Human Microbiome Therapeutics Market
• 14.13. France Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 14.14. France Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

15. Eastern Europe Human Microbiome Therapeutics Market

• 15.1. Eastern Europe Human Microbiome Therapeutics Market Overview
  • 15.1.1. Region Information
  • 15.1.2. Impact Of COVID-19
  • 15.1.3. Market Information
  • 15.1.4. Background Information
  • 15.1.5. Government Initiatives
  • 15.1.6. Regulations
  • 15.1.7. Regulatory Bodies
  • 15.1.8. Major Associations
  • 15.1.9. Taxes Levied
  • 15.1.10. Corporate Tax Structure
  • 15.1.11. Investments
  • 15.1.12. Major Companies
• 15.2. Eastern Europe Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 15.3. Eastern Europe Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 15.4. Eastern Europe Human Microbiome Therapeutics Market: Country Analysis
• 15.5. Russia Human Microbiome Therapeutics Market
• 15.6. Russia Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 15.7. Russia Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

16. North America Human Microbiome Therapeutics Market

• 16.1. North America Human Microbiome Therapeutics Market Overview
  • 16.1.1. Region Information
  • 16.1.2. Impact Of COVID-19
  • 16.1.3. Market Information
  • 16.1.4. Background Information
  • 16.1.5. Government Initiatives
  • 16.1.6. Regulations
  • 16.1.7. Regulatory Bodies
  • 16.1.8. Major Associations
  • 16.1.9. Taxes Levied
  • 16.1.10. Corporate Tax Structure
  • 16.1.11. Investment
  • 16.1.12. Major Companies
• 16.2. North America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 16.3. North America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 16.4. North America Human Microbiome Therapeutics Market: Country Analysis
• 16.5. USA Human Microbiome Therapeutics Market
• 16.6. USA Human Microbiome Therapeutics Market Overview
  • 16.6.1. Country Information
  • 16.6.2. Impact Of COVID-19
  • 16.6.3. Market Information
  • 16.6.4. Background Information
  • 16.6.5. Government Initiatives
  • 16.6.6. Regulations
  • 16.6.7. Regulatory Bodies
  • 16.6.8. Major Associations
  • 16.6.9. Corporate Tax Structure
  • 16.6.10. Investments
  • 16.6.11. Major Companies
• 16.7. USA Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 16.8. USA Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

17. South America Human Microbiome Therapeutics Market

• 17.1. South America Human Microbiome Therapeutics Market Overview
  • 17.1.1. Region Information
  • 17.1.2. Market Information
  • 17.1.3. Impact Of COVID-19
  • 17.1.4. Background Information
  • 17.1.5. Government Initiatives
  • 17.1.6. Regulations
  • 17.1.7. Regulatory Bodies
  • 17.1.8. Major Associations
  • 17.1.9. Taxes Levied
  • 17.1.10. Corporate Tax Structure
  • 17.1.11. Investments
  • 17.1.12. Major Companies
• 17.2. South America Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 17.3. South America Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)
• 17.4. South America Human Microbiome Therapeutics Market: Country Analysis
• 17.5. Brazil Human Microbiome Therapeutics Market
• 17.6. Brazil Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 17.7. Brazil Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

18. Middle East Human Microbiome Therapeutics Market

• 18.1. Middle East Human Microbiome Therapeutics Market Overview
  • 18.1.1. Region Information
  • 18.1.2. Market Information
  • 18.1.3. Impact Of COVID-19
  • 18.1.4. Background Information
  • 18.1.5. Government Initiatives
  • 18.1.6. Regulations
  • 18.1.7. Regulatory Bodies
  • 18.1.8. Major Associations
  • 18.1.9. Taxes Levied
  • 18.1.10. Corporate Tax Structure
  • 18.1.11. Investments
  • 18.1.12. Major Companies
• 18.2. Middle East Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 18.3. Middle East Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

19. Africa Human Microbiome Therapeutics Market

• 19.1. Africa Human Microbiome Therapeutics Market Overview
  • 19.1.1. Region Information
  • 19.1.2. Market Information
  • 19.1.3. Impact Of COVID-19
  • 19.1.4. Background Information
  • 19.1.5. Government Initiatives
  • 19.1.6. Regulations
  • 19.1.7. Regulatory Bodies
  • 19.1.8. Major Associations
  • 19.1.9. Taxes Levied
  • 19.1.10. Corporate Tax Structure
  • 19.1.11. Investments
  • 19.1.12. Major Companies
• 19.2. Africa Human Microbiome Therapeutics Market, Forecast Market Growth, 2023 - 2030, Value ($ Million)
• 19.3. Africa Human Microbiome Therapeutics Market, Segmentation By Disease, Forecast, 2023 - 2030, Value ($ Million)

20. Global Human Microbiome Therapeutics Market Competitive Landscape

• 20.1. Company Profiles
• 20.2. Seres Therapeutics
  • 20.2.1. Company Overview
  • 20.2.2. Products And Services
  • 20.2.3. Business Strategy
  • 20.2.4. Financial Overview
• 20.3. Assembly Biosciences
  • 20.3.1. Company Overview
  • 20.3.2. Products And Services
  • 20.3.3. Business Strategy
  • 20.3.4. Financial Overview
• 20.4. Enterome Bioscience
  • 20.4.1. Company Overview
  • 20.4.2. Products And Services
  • 20.4.3. Business Strategy
  • 20.4.4. Financial Overview
• 20.5. Vedanta BioSciences
  • 20.5.1. Company Overview
  • 20.5.2. Products And Services
  • 20.5.3. Business Strategy
  • 20.5.4. Financial Overview
• 20.6. Second Genome Inc.
  • 20.6.1. Company Overview
  • 20.6.2. Products And Services
  • 20.6.3. Business Strategy
  • 20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Human Microbiome Therapeutics Market

• 21.1. Janssen Collaborated With Kaleido Biosciences
• 21.2. Ritter Pharmaceuticals Merged With Qualigen, Inc.
• 21.3. Ferring Pharmaceuticals Acquired Rebiotix
• 21.4. Monsanto Collaborated With Second Genome

22. Human Microbiome Therapeutics Market Opportunities And Strategies

• 22.1. Global Human Microbiome Therapeutics Market In 2030 - Countries Offering Most New Opportunities
• 22.2. Global Human Microbiome Therapeutics Market In 2030 - Segments Offering Most New Opportunities
• 22.3. Global Human Microbiome Therapeutics Market In 2023 - Growth Strategies
  • 22.3.1. Market Trend Based Strategies
  • 22.3.2. Competitor Strategies

23. Microbiome Homes Market, Conclusions And Recommendations

• 23.1. Conclusions
• 23.2. Recommendations
  • 23.2.1. Product
  • 23.2.2. Place
  • 23.2.3. Price
  • 23.2.4. Promotion
  • 23.2.5. People

24. Appendix

• 24.1. Market Data Sources
• 24.2. Research Methodology
• 24.3. Currencies
• 24.4. Research Inquiries
• 24.5. The Business Research Company
• 24.6. Copyright and Disclaimer